Three ovarian cancer lines, the sex steroid hormone-responsive lines OVCAR-3 and OAW-42 and the hormone-unresponsive, HER-2 overexpressing line SK-OV-3, were treated with 0, 100 and 400 ng/mL of huChem-157. Here, ERBB2 is linked to ovarian carcinoma.